J P Morgan Healthcare Conference

9-11 January 06, San Francisco

TAT2006 (Targeted Anticancer Therapies)

16-18 March 2006, Amsterdam

www.nddo.org

The 4th International Symposium on Targeted Anticancer Therapies (TAT 2006) has demonstrated that this annual meeting series has come of age. It provides an excellent forum for the presentation and discussion of virtually all aspects of targeted anticancer therapies in (pre)clinical development. TAT 2006 was the second meeting in this series organized as a partnership meeting between the NDDO Research Foundation and ESMO

BioCapital Europe

21 March 06, Amsterdam

www.biocapitaleurope.com

BioCapital Europe showcases the most promising investment opportunities in the biotech sector to an elite group of investors. The companies selected to present range from early stage to late stage investment opportunities. The conference centres around company presentations and allows investors to closely interact with various companies and their senior executives. Attendance by invitation only.

AACR (American Association for Cancer Research)

1-5 April 06, Washington DC

www.aacr.org.com

The AACR Annual Meeting is the most important cancer research meeting in the world. Attendance is essential for all who are committed to learning about the latest discoveries and trends across the entire spectrum of cancer research. This year’s theme centered on new and promising therapeutic approaches and was reflected in the Opening Plenary Session titled “Looking into the Future of Cancer Therapy”.

BIO2006 Chicago

10-12 April 06

www.bio.org/events/2006

BIO represents more than 1100 biotechnology companies, academic institutions, state biotechnology centers and related organisations across the US and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.

BioWindhover

15-17 May 2006, Washington DC

www.biowindhover.com

Major networking event with approximately 400 senior decision makers attending from the R&D and business development:sector. The meeting provides pharmaceutical firms with a targeted group of companies that fill particular pipeline or technology needs, and also provide those select biotechs with an opportunity to meet face-to-face with senior pharmaceutical business and scientific management responsible for deal-making.

BioEquity Europe

23 May 2006, Frankfurt

www.biocentury.com

The 7 th Anniversary Meeting supported by Nomura Phase4 Ventures which brings together professional investors, bankers and analysts with leading public and late stage private companies.

42nd ASCO Annual Meeting (American Society of Clinical Oncology)

2-6 June 2006, Atlanta

www.asco.org

The ASCO Annual Meeting is considered the premier educational and scientific event in the oncology community. The 2005 Meeting in Orlando attracted more than 29,000 attendees from all over the world.

Windhover - Therapeutic Oncology Alliances Conference

6-7 June 2006, Atlanta

www.oncologyalliances.com

Windhover's TA ONCOLOGY meeting brings research and business development together into a more productive initial meeting, focused on the researcher's area of interest and capitalises on potential new business and collaboration opportunities with the hottest oncology in-licensers and out-licensers.

11th Congress of the Hematology Association

14-16 June 2006, Amsterdam

www. congress.ehaweb.org/11th

Expert hematologists presenting their timely views in sessions of a different scope covering both benign and malignant hematology. Delegates participate in high quality Education, Meet-the-Expert, Hematology-in-Focus and Plenary sessions, as well as in challenging Lunch Debates, Clinical Trial Updates and Science-in-Progress sessions.

BioPharmaceutical Conference in Europe

14-16 June 2006, Lisbon

www.biopharmconference.com

This is an exclusive 'by invitation only' event, which provides a unique setting for like-minded individuals, at the most senior level to meet and explore new business opportunities in a relaxed, informal setting away from day to day business distractions. The programme offers formal keynote presentations as well as lively panel discussions.

23rd Int. Conf. Advances in application of Monoclonal Antibodies in Clinical Oncology

26-28 June 2006, Mykonos, Greece

Speakers are renowned experts in their fields presenting the most recent and exciting work in the tumour targeting arena.

5th Annual EC21 BioVentures Conference

22-23 March 2005, London

BioVenture Leadership Session: "Getting Bigger and Better – M&A Activity in Europe "

IJN joined a panel of experts to discuss the practical realities of M&A activity in Europe

www.techvision/com/ec21

SG Cowen & Co. 25th Annual Health Care Conference

14-17 March 2005, Boston

Presentations from top management of over 250 high interest companies

www.sgcowen.com/PastConferences.asp

BioCapital Europe - Fortis Bank Life Science Partners

1 March 2005, Amsterdam

Life science companies from throughout Europe presented their latest innovations and developments.

www.biocapitaleurope.com

Investing in European Biotechnology: Risks and Rewards

1 December 2004, Madrid

Conference arranged by Gilde Investment Management in association with a Spanish Institution. Ian Nicholson presented on "The European Biotech SME Perspective"

BioBusiness Network 2005

25-28 January 2005
President Wilson Hotel, Geneva

http://www.wbresearch.com/biobusinessnetwork

The Third Swiss Re Private Equity Forum

15 September 2004
Centre for Global Dialogue, Rüschlikon, Switzerland

This half-day event and executive dinner, targeted a limited number of institutional investors and featured speakers from the entire private equity value chain (institutional investors, fund of funds managers, fund managers and portfolio companies). As well as gaining insight into the latest developments and prognoses, participants also had the chance to hear institutional investors’ views on how and why one should invest in private equity, and assess the contribution of each of the above mentioned players to the value chain.

12th Annual Atlas Venture Life Sciences Conference

19-21 September 2004
Palais de la Méditerranée, Nice

http://www.atlasventure.com/LSC/content.asp?id=6

4th Annual Biotech in Europe Investor Forum

Organised by Sachs Associates in association with Bloomberg LP

5-6 October 2004
Swissôtel Zurich, Switzerland

http://www.sachsforum.com/zurich2004_fs.html

Chroma Announces Positive Phase I Efficacy Data for Novel Cancer Therapy CHR-2797

Chroma to Present Phase I Efficacy Data for Novel Cancer Therapy CHR-2797

Cell Accumulation Approach